March 29, 2021

Zou Lab's new Nature Immunology article

Congratulations to the Zou lab (Karolina, Houjun, and Jiajia) on their new Nature Immunology article, "The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity!" Please read more about their findings in this news release.

Weiping Zou

Weiping Zou, M.D., Ph.D.

Charles B. de Nancrede Professor; Professor of Surgery, Immunology, and Biology
Director, Center of Excellence for Cancer Immunology and Immunotherapy
Co-Director, Cancer Hematopoiesis and Immunology Program
Director, Translational Research; Co-Director, Immune Monitoring Core
Accepting Students?